Avant Diagnostics
Scottsdale, US · Nevada corporation
Founders & leadership
GL
Gregg LinnExecutive
RL
Randall LetcavageExecutive
Board
JR
Joseph RothBoard director
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 2 rounds · 2016–2018
▶$1.2MraisedJun 2018 · 8 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJun 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael Ruxin, M.D.Executive Officer
- Scott VanderMeerExecutive Officer
- Jeff BuschDirector
- Robert TrappDirector
- John BrugmannDirector
- Jeff StephensDirector
- Offering amount
- $2M
- Amount sold
- $1.2M
- Minimum investment
- $100K
- Sales commissions
- $52K
- Placement agents
- Dominick & Dickerman LLC
- First sale
- May 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$112.5KraisedJan 2016 · 1 investors · BiotechnologyRule 506(b)
▶$112.5KraisedJan 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregg LinnExecutive Officer, Director
- Joseph RothDirector
- Randall LetcavageDirector
- Offering amount
- $112.5K
- Amount sold
- $112.5K
- Minimum investment
- $112.5K
- First sale
- Jan 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Avant Diagnostics raised?
- Avant Diagnostics has disclosed $1.3M raised across 2 rounds.
- Where is Avant Diagnostics headquartered?
- Avant Diagnostics is headquartered in Scottsdale, US.